A novel selective multi-targeted tyrosine kinase inhibitor with superior anti-tumor efficacy

被引：0
|
作者：
Hjarnaa, P. [1 ]
Fensholdt, Jef [1 ]
机构：
[1] LEO Pharma AS, Ballerup, Denmark
来源：
INFLAMMATION RESEARCH | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：S464 / S465
页数：2
相关论文
共 50 条
  • [31] Multi-targeted tyrosine kinase inhibitor Cabozantinib as a therapeutic agent in MET-overexpressing gastric cancer
    Choi, Audrey H.
    Lu, Jianming
    Lee, Sangjun
    Chu, Peiguo
    Chung, Vincent
    Lin, Ren-Jang
    Kim, Joseph
    Chao, Joseph
    CANCER RESEARCH, 2015, 75
  • [32] MEDI 301-ABT-869, an orally active multi-targeted receptor tyrosine kinase inhibitor
    Dai, Yujia
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [33] A Phase I Study of the Multi-Targeted Tyrosine Kinase Inhibitor Cabozantinib in Patients with Acute Myeloid Leukemia
    Fathi, Amir T.
    Blonquist, Traci M.
    Levis, Mark J.
    Hernandez, Daniela
    Ballen, Karen K.
    Avigan, David E.
    Joyce, Robin
    McMasters, Malgorzata
    Logan, Emma
    Hobbs, Gabriela S.
    Brunner, Andrew M.
    Connolly, Christine
    Perry, Ashley M.
    Joseph, Christelle
    Som, Tina T.
    Ramos, Aura Y.
    Neuberg, Donna S.
    Amrein, Philip C.
    BLOOD, 2016, 128 (22)
  • [34] Prodrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor Sunitinib
    Huang, Qiang
    Zhou, Changhua
    Chen, Xiao
    Dong, Bing
    Chen, Siqi
    Zhang, Ning
    Liu, Yawei
    Li, Anrong
    Yao, Meicun
    Miao, Ji
    Li, Qing
    Wang, Zhong
    PLOS ONE, 2015, 10 (10):
  • [35] Multi-targeted tyrosine kinase inhibitors and VEGFR-targeting agents
    Eckhardt, SG
    ANNALS OF ONCOLOGY, 2006, 17 : 20 - 20
  • [36] Potential Efficacy of Multi-targeted Tyrosine Kinase Inhibitors in Non-small-cell Lung Cancer
    Chen, Jinfei
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (05) : 322 - 322
  • [37] Preclinical development of a novel multi-targeted kinase inhibitor, MG516, for the treatment of sarcoma
    Ivy, Kathryn S.
    Patwardhan, Parag P.
    Schwartz, Gary K.
    CANCER RESEARCH, 2014, 74 (19)
  • [38] Anti-Anaplastic Thyroid Cancer (ATC) Effects and Mechanisms of PLX3397 (Pexidartinib), a Multi-Targeted Tyrosine Kinase Inhibitor (TKI)
    Luo, Jingtao
    Wang, Yun
    Zhao, Lingkun
    Wang, Chunli
    Zhang, Ze
    CANCERS, 2023, 15 (01)
  • [39] Profound Hair and Skin Hypopigmentation in an African American Woman Treated With the Multi-Targeted Tyrosine Kinase Inhibitor Pazopanib
    Sideras, Kostandinos
    Menefee, Michael E.
    Burton, Jill K.
    Erlichman, Charles
    Bible, Keith C.
    Ivy, S. Percy
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : E312 - E313
  • [40] A lymphatic-absorbed multi-targeted kinase inhibitor for myelofibrosis therapy
    Ross, Brian D.
    Jang, Youngsoon
    Welton, Amanda
    Bonham, Christopher A.
    Palagama, Dilrukshika S. W.
    Heist, Kevin
    Boppisetti, Jagadish
    Imaduwage, Kasun P.
    Robison, Tanner
    King, Leah R.
    Zhang, Edward Z.
    Amirfazli, Cyrus
    Luker, Kathryn E.
    Lee, Winston Y.
    Luker, Gary D.
    Chenevert, Thomas L.
    Van Dort, Marcian E.
    NATURE COMMUNICATIONS, 2022, 13 (01)
12345